1-(6-CHLOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXYLIC ACID, 95%, 100mg

1-(4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-3-(m-tolyl)urea, 98%, 250mg

2-(2,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

N-Methyl-N-(6-quinolinylmethyl)amine, 97.0%, 100mg

1,4-Diazabicyclo[2.2.2]octane>98.0%(GC)(T)500g

Propanoic acid, 3-(2-hydroxyethoxy)-, 95%, 1g

4-(4H-1,2,4-triazol-3-yl)pyridine, 95.0%, 1g

(S)-5-methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 98%, 100mg

2-amino-N-(furan-2-ylmethyl)acetamide hydrochloride, 95.0%, 2.5g

Palmitic acid, min. 98%, extra pure, 5 kg, plastic packaging.

1-(Benzyloxy)-3-(prop-2-yn-1-yl)benzene, 97%, 100mg

HPLC column NUCLEODUR® C18 Gravity 3 µm, 150 mm, 4.6 mm, 1 Piece(s)

3-Chloro-5-fluorobenzotrifluoride, 97.0%, 5g